NR3C1 and breast carcinoma: Zbtb16 expression is activated by the glucocorticoid receptor (NR3C1) in many cell types, including hepatocytes [110], breast cancer cell line [111], endometrial stromal cells, and myometrial smooth muscle cells [112].